Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Arch Biochem Biophys. 2013 Aug 11;538(1):10.1016/j.abb.2013.08.002. doi: 10.1016/j.abb.2013.08.002

Fig. 1.

Fig. 1

TnI and MYBP-C phosphorylation in heart failure. Myocardial homogenates from heart failure and donor patients were resolved by SDS–PAGE and stained successively with ProQ Diamond phosphoprotein (top panels in A and B) and Deep Purple total protein stain (bottom panels in A and B). There were statistically significant decreases in total phosphorylation of both MYBP-C (A) and TnI (B) in the heart failure samples. Further analyses of site specific Ser23/24 phosphorylation of TnI by Western blotting demonstrated a concurrent 41% decrease in the heart failure samples (C) without a change in total TnI expression (D). *Denotes P < 0.05 vs. donor.